<DOC>
	<DOCNO>NCT00406588</DOCNO>
	<brief_summary>This study multicenter , randomize , double blind , parallel group study 3 month ' treatment SLV308 administer monotherapy patient advance stage PD . An open label safety extension study plan separate protocol patient willing eligible participate .</brief_summary>
	<brief_title>SLV308 Treatment Patients With Parkinson 's Disease Experiencing Motor Fluctuations</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Diagnosis idiopathic Parkinson 's Disease , advance stage disease , Modified Hoehn &amp; Yahr stage IIIV , presence recognizable 'on ' 'off ' state ( motor fluctuation ) stable treatment levodopa least 28 day prior randomization 'onoff ' phenomenon 'yoyoing ' and/or abrupt unpredictable loss efficacy unrelated timing LDOPA administration , Prevalent expression troublesome dyskinesia 'on ' time waking hour , Diagnosis unclear suspicion parkinsonian syndrome exists , Previous surgery treatment PD</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Parkinson Disease</keyword>
</DOC>